Ripretinib
5 interactions 1 explained in plain EnglishRipretinib is used to treat gastrointestinal stromal tumors (GIST; a type of tumor that grows in the stomach, intestine [bowel], or esophagus [tube that connects the throat with the stomach]) in adults who have previously received other medications, including imatinib (Gleevec). Ripretinib is in a class of medications… Read the full Ripretinib drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Ripretinib Abametapir Explained Increased exposure of CYP3A4 substrate Details Ripretinib Letermovir Injection Prevymis Increased CYP3A substrate exposure Details Ripretinib Nafcillin Injection Unipen® Injection Decreased exposure of ripretinib and its active metabolite and reduction of antitumor activity DetailsModerate
Ripretinib Ketoconazole Topical Extina® Foam Increased exposure of ripretinib and its active metabolite and increased risk of adverse reactions Details Ripretinib Levothyroxine Ermeza Increased risk of hypothyroidism DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist